哈佛啟動新人體試驗
A New Clinical Trial Was Initiated to Save Parkinson’s Disease.
第31屆美國抗老暨再生醫學會特輯(三)
Induced pluripotent stem cells were considered as a solution for Parkinson’s disease. However, the implanted cells were not found to bring up the surprising results for the patients. The possible reason could be the iPSCs did not survive well after transplantation. Dr. Kim working in McLean hospital announced that he would initiate a clinical trial to test the effect of a new molecule called HL192 which could increase the survival rate of the implanted iPSCs.
請點擊和訂閱 #王麗惠醫師新知報報 #王麗惠的星靈宙語
Facebook頻道連結⬇
/ drwanglawyer
"請幫我按讚轉發和訂閱，您的支持是我最大的鼓勵"
✨王麗惠醫師✨
• 康普頓生物科技有限公司董事長
• 康維特生醫有限公司董事長
• 美國抗老暨再生醫學會專科醫師
• 中華民國律師
• 美國營養學院認證營養學專科醫師
• 康普頓診所副院長
• 中華民國中西雙執照醫師
• 中華民國斐陶斐榮譽會員
• 東海大學法律碩士
• 東海大學推廣部樂齡大學兼任講師
• 上海宮氏信息針刺法傳人
✅了解更多
https://taplink.cc/drwanglawyer